North Andover, MA, United States of America

Doris Peterkin

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Oncopep, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Doris Peterkin. Retrieved from https://idiyas.com/inventor/doris-peterkin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Doris Peterkin: Innovator in Cancer Treatment

Introduction

Doris Peterkin is a notable inventor based in North Andover, MA (US). She has made significant contributions to the field of cancer treatment, particularly through her innovative work on peptide vaccines.

Latest Patents

Doris holds 1 patent for her invention titled "Peptide vaccines and pembrolizumab for treating breast cancer." This patent features combination therapies that include pembrolizumab and one or more immunogenic XBP1-, CD138-, and CS1-derived peptides. These therapies are designed to induce an immune response in subjects with cancer, specifically targeting breast cancer, including triple-negative breast cancer.

Career Highlights

Doris is currently employed at Oncopep, Inc., where she continues to advance her research and development efforts in cancer therapies. Her work is pivotal in the ongoing fight against breast cancer, showcasing her dedication to improving patient outcomes.

Collaborations

Doris collaborates with Marc Andrew Cohen, contributing to the innovative environment at Oncopep, Inc. Their partnership exemplifies the importance of teamwork in scientific research and development.

Conclusion

Doris Peterkin's contributions to cancer treatment through her patented innovations highlight her role as a leading inventor in the medical field. Her work continues to inspire advancements in cancer therapies, making a significant impact on patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…